MedTrace Logo

Medical Education to Improve Diabetes Care and Outcomes in Hospitalized Patients

NCT07108426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-08-07

No results posted yet for this study

Summary

This clinical trial aims to evaluate whether a structured medical education strategy can improve the quality of care provided to hospitalized patients with diabetes or hyperglycemia. Internal medicine residents from four university hospitals in southern Brazil are assigned to two groups: an intervention group receiving a 30-minute online lecture and 30 days of educational follow-up via WhatsApp®, and a control group receiving no additional training.

The primary goal is to assess changes in physicians' knowledge about inpatient glycemic control. Secondary goals include evaluating the quality of insulin prescriptions, rates of hyperglycemia and hypoglycemia, and hospital length of stay.

Conditions

  • Diabete Type 2
  • Hyperglycemic Therapy
  • Medical Education
  • Telemedecine

Interventions

BEHAVIORAL

Educational Intervention via Telemedicine

A structured educational program delivered remotely through WhatsApp®, including a 30-minute online lecture and daily dissemination of educational content (videos, texts, and practical guidance) on hospital hyperglycemia and glycemic management strategies.

Sponsors & Collaborators

  • Federal University of Health Science of Porto Alegre

    collaborator OTHER

  • Universidade Federal do Rio Grande (FURG)

    collaborator OTHER

  • Federal University of Pelotas

    collaborator OTHER

  • Catholic University of Pelotas

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07108426 on ClinicalTrials.gov